Skip to main content
2026 Prospectus
Alzheimer’s & Brain Awareness Month 2026 executive observance hero.

· Executive Brief

Alzheimer’s & Brain Awareness Month 2026

A practical executive framework for access, ownership, handoffs, measurement, and improvement.

Greg Wahlstrom in his office at The Healthcare Executive
Written byMBAHCMPresident and Chief Executive Officer, The Healthcare ExecutiveOctober 2026 30 min read

Leadership signal

Alzheimer’s & Brain Awareness Month can serve as an executive operating checkpoint.

Awareness can generate questions and requests for help. Executive teams can prepare by clarifying the first point of contact, the qualified team that accepts the request, the handoff standard, and the method used to verify completion without assuming that one route fits every person.

Start by distinguishing what is known from what the organization still needs to learn. A campaign plan, communication volume, or meeting count does not establish that a route is usable. Leaders need direct listening, clear ownership, locally defined measures, and a method for keeping exceptions visible.

Executive opening

Dementia care is a route that starts long before a specialist visit

Dementia care begins in ordinary places: a primary care visit, a family member’s phone call, a senior center or an emergency department. From there, people need recognition, diagnosis, treatment decisions, caregiver support and, eventually, end-of-life care. Each step depends on the one before it, and each is often owned by a different team or organization. When any step fails, the person and the family usually absorb the delay. Families often describe months of uncertainty before anyone names the problem. For health systems, that uncertainty shows up as repeat visits, crisis admissions and caregivers who reach the limits of what they can manage alone.

The first step is often the weakest. In an Italian real-world survey covering 325 patients, physicians most commonly attributed diagnostic delays to limited specialist access (55.8%).[1] Prolonged intervals between consultations (27.0%) and restricted diagnostic resources (20.4%) followed.[1] Biomarker testing remained uncommon, with cerebrospinal fluid testing in 15.9% and amyloid imaging in 16.3% of cases.[1]

Treatment follow-through is also fragile. In a nationally representative U.S. sample of 1299 newly diagnosed patients, 26% filled a dementia prescription within 90 days of diagnosis.[15] Among people who started treatment, 44% were non-adherent during the following year.[15] New amyloid-targeting therapies raise the stakes further, because they create an urgent need to identify eligible patients efficiently in primary care.[6]

Equity gaps run through the entire route, from medication use to hospice. They are not limited to a single service line. Alzheimer’s & Brain Awareness Month gives executives a moment to ask where their own route breaks and who owns each repair. The sections below summarize peer-reviewed evidence on detection, access, caregiver support, transitions, equity, workforce and communication. They are meant to sit beside the executive guidance already on this page. Taken together, they describe a route that leaks at predictable points.

Current evidence

What current research shows about detection, treatment and outcomes

Detection in primary care can improve with tools designed for the setting. In an independent primary care cohort of 403 patients across 19 centers, a brief self-administered digital test had 85% accuracy for cognitive impairment.[6] Primary care physician assessment had 73% accuracy, and the test reached 90% with a two-cutoff approach.[6] Combined with a blood test, it identified biomarker-verified Alzheimer’s disease with 90% accuracy, compared with 70% for standard care.[6]

Low-burden approaches using existing data also show promise. A prospective cross-sectional study combined a passive digital marker from electronic health records with a brief rating questionnaire.[2] Each method alone showed limited discrimination, with an area under the curve of 0.61 to 0.62.[2] The combined model reached 0.79, with sensitivity of 0.75 and specificity of 0.71.[2] The authors suggested it may support risk stratification and referral prioritization.[2] Because the marker draws on records the system already holds, it adds little burden to busy clinics. That makes it a candidate for population-level outreach, subject to local validation.

Implementation evidence matters as much as test accuracy. In one family medicine clinic, 21 primary care providers serving 2733 eligible patients used a digital cognitive assessment given by medical assistants.[7] The tool was adopted by 95% of providers, who were more likely to diagnose cognitive disorders (adjusted odds ratio 1.72).[7] Practice-wide diagnosis rates stayed elevated after research support ended.[7]

Downstream outcomes reveal how much happens after diagnosis. In North and South Carolina Medicare claims from 2013 to 2017, Black beneficiaries had a 4% higher risk of all-cause hospitalization than White beneficiaries after adjustment.[14] They spent 14% fewer days in hospice and were 38% less likely to receive physical or occupational therapy.[14] Nationally, 1,523,142 hospital stays among 945,481 Medicare enrollees with dementia were analyzed for readmission.[12] Black beneficiaries had 37% higher unadjusted odds of 30-day readmission.[12]

Most of this evidence is observational or drawn from single programs. It shows where routes leak and which groups are affected. It does not establish that a given tool will perform the same way in another system without attention to workflow. Leaders should treat each finding as a reason to examine local data. The most useful comparison is usually the organization against its own baseline, stratified by the groups it serves. Where local data do not exist, creating them is the first improvement.

Figure 1

Dementia routes leak at diagnosis, testing and treatment follow-through

Dementia routes leak at diagnosis, testing and treatment follow-throughPercent of patients or callers, as reported in each study. Values are copied from the cited studies [1], [11], [15]; none is estimated.0%25%50%75%100%Diagnostic delay attributed to limitedspecialist accessDiagnostic delay attributed to limited specialist access: 55.8% (source [1])55.8%[1]Amyloid imaging performedAmyloid imaging performed: 16.3% (source [1])16.3%[1]Filled a dementia prescription within 90days of diagnosisFilled a dementia prescription within 90 days of diagnosis: 26% (source [15])26%[15]Non-adherent in the year after startingtreatmentNon-adherent in the year after starting treatment: 44% (source [15])44%[15]Callers with an indication for an on-site visit after telephone triageCallers with an indication for an on-site visit after telephone triage: 66.7% (source [11])66.7%[11]Source [1]Source [15]Source [11]Shade and hatching group bars by study; the studies differ in population and setting, so bars compare only within a shade

Percent of patients or callers, as reported in each study. Values are copied from the cited studies [1], [11], [15]; none is estimated.

Data note. These values come from different studies, countries, years and denominators, so this is an indirect comparison; the bars show where the route leaks, not how one step compares with another.

Limitation. Italian values are physician-reported; U.S. medication data predate new therapies; the triage figure is from one clinic.

Figure data (5 rows)
Figure 1 data: Dementia routes leak at diagnosis, testing and treatment follow-through
MeasureValuePopulation, setting and year as reportedSource
Diagnostic delay attributed to limited specialist access55.8%Physician-reported data on 325 patients with mild cognitive impairment or mild Alzheimer disease dementia, Italy[1]
Amyloid imaging performed16.3%Same Italian real-world survey[1]
Filled a dementia prescription within 90 days of diagnosis26%1299 newly diagnosed U.S. patients, survey linked with Medicare and Medicaid claims, 2000 to 2016[15]
Non-adherent in the year after starting treatment44%1343 U.S. patients initiating dementia medication, same study[15]
Callers with an indication for an on-site visit after telephone triage66.7%Callers requesting a first assessment at one specialized outpatient memory clinic after triage began[11]
A family physician listens to an older Black man and his adult daughter describe his recent forgetfulness.
Illustrative image. A workflow-integrated digital assessment increased cognitive diagnoses in primary care.[7]

Continuum of care

Where the dementia route breaks between detection, diagnosis and end of life

The route from concern to assessment is the first handoff. A cluster-randomized trial in Munich senior centers enrolled 473 older adults with subjective cognitive concerns.[3] Feasibility and acceptability of community-based, tiered detection were high.[3] Yet limited general practitioner engagement showed the need for stronger integration with primary care to ensure downstream diagnostics.[3] Detection that does not connect to a clinician leaves people with results and no next step. Community partners need a named clinical receiver, an agreed referral format and a way to learn what happened. Without those elements, outreach can raise anxiety without improving care.

The route from diagnosis to treatment is the second handoff. In the U.S. medication study, 36% of newly diagnosed patients filled a dementia prescription within 365 days.[15] Among those who started, 24% discontinued during the year after initiation.[15] The authors noted that non-adherence and discontinuation may relate to cost and access to care.[15] Leaders should know who owns follow-up after the first prescription, not only who writes it.

Hospital transitions are a third pressure point. The national readmission study found that Black beneficiaries’ higher readmission odds persisted after adjustment for geographic, social, hospital, stay-level and demographic factors.[12] After adjusting for comorbidities, the odds ratio was still 1.16.[12] The authors suggested that racially patterned differences in care account for part of the gap.[12] Discharge planning for people with dementia therefore deserves its own equity review. That review should include caregiver readiness, follow-up appointments and medication reconciliation. Each of these steps can fail quietly after a patient leaves.

End-of-life care is the final transition. Among 673,102 people with dementia enrolled in 4371 hospices, disenrollment was more likely in hospices in the lowest quality quartile.[13] It was substantially higher in unrated hospices, with adjusted odds ratios of 1.8 to 2.0.[13] Within both low- and high-quality hospices, minoritized people with dementia were more likely to be disenrolled than White people.[13]

Each of these handoffs crosses organizational boundaries. Senior centers, primary care, specialists, pharmacies, hospitals, post-acute providers and hospices each hold one piece. The executive task is to make sure every piece has a receiving owner and a visible status. Families should not have to carry information from one setting to the next. When they do, details are lost and plans are repeated or forgotten.

Figure 3

Why the pathway breaks

Cause-and-effect diagram: People with cognitive concerns are not diagnosed, treated, supported and followed through to end-of-life care in a timely and equitable wayUnranked qualitative cause-and-effect diagram for the outcome in the box: People with cognitive concerns are not diagnosed, treated, supported and followed through to end-of-life care in a timely and equitable way Causes are assembled from the cited literature [1], [3], [5], [6], [7], [10], [11], [12], [13], [14], [15]; categories are not weighted and their order carries no meaning.People with cognitive concernsare not diagnosed, treated,supported and followed throughto end-of-life care in atimely and equitable wayPeopleProcessTechnologyEnvironmentPolicyMeasurement

People

  • Primary care clinicians lack geriatric and dementia training
  • Limited specialist capacity and long intervals between consultations
  • Caregivers unsupported and unprepared

Process

  • No triage for memory clinic referrals
  • Detection results not linked to a primary care next step
  • No owner for medication follow-through after the first prescription

Technology

  • Brief paper tests lack sensitivity in primary care
  • Assessment results not integrated in the health record
  • Limited access to biomarker testing

Environment

  • Neurologist shortages in high-incidence counties
  • Community settings disconnected from primary care
  • Hospice quality varies across providers

Policy

  • Cost barriers to medication and biomarkers
  • Rising demand from new amyloid-targeting therapies
  • Unrated hospices outside public reporting

Measurement

  • Diagnosis rates not tracked at practice level
  • Readmission and hospice use not stratified by race
  • Low-value end-of-life care not monitored

Unranked qualitative cause-and-effect diagram for the outcome in the box: People with cognitive concerns are not diagnosed, treated, supported and followed through to end-of-life care in a timely and equitable way Causes are assembled from the cited literature [1], [3], [5], [6], [7], [10], [11], [12], [13], [14], [15]; categories are not weighted and their order carries no meaning.

Data note. Qualitative; no frequencies are implied.

Limitation. Causes drawn from published studies may not all apply locally; validate them with frontline teams.

Figure data (6 rows)
Figure 3 data: Why the pathway breaks
CategoryCauses drawn from the cited literature
PeoplePrimary care clinicians lack geriatric and dementia training; Limited specialist capacity and long intervals between consultations; Caregivers unsupported and unprepared
ProcessNo triage for memory clinic referrals; Detection results not linked to a primary care next step; No owner for medication follow-through after the first prescription
TechnologyBrief paper tests lack sensitivity in primary care; Assessment results not integrated in the health record; Limited access to biomarker testing
EnvironmentNeurologist shortages in high-incidence counties; Community settings disconnected from primary care; Hospice quality varies across providers
PolicyCost barriers to medication and biomarkers; Rising demand from new amyloid-targeting therapies; Unrated hospices outside public reporting
MeasurementDiagnosis rates not tracked at practice level; Readmission and hospice use not stratified by race; Low-value end-of-life care not monitored

Access

Making assessment, specialist review and new therapies reachable

Specialist capacity is the most visible access constraint. Memory clinics, unlike emergency departments, have generally lacked formal triage systems.[11] A specialized outpatient memory clinic introduced psychological telephone triage, led by a clinical psychologist, for people requesting a first assessment.[11] After it began, 66.7% of callers had an indication for an on-site visit.[11] A further 14% received telephone counseling, giving a 34% reduction in on-site visits.[11]

The triage study also found that patients classed as acute had the shortest waiting time.[11] They presented with the most severe cognitive and functional symptoms at the visit.[11] For executives, that is an example of matching scarce specialist time to need rather than to order of arrival. It also shows that counseling can be a legitimate service outcome, not a failure to schedule. Similar triage could help systems manage demand for new therapy evaluations. The principle is simple: sort requests by need before they reach the scarcest clinicians.

Primary care tools can widen the front door when they fit existing roles. The digital assessment was given by medical assistants with results placed in the electronic health record.[7] Integration with clinic staff workflow yielded high adoption and sustainability.[7] The digital test and blood test study showed that a brief self-administered battery can detect cognitive impairment in primary care.[6] These designs reduce the number of patients who must wait for a specialist only to establish that impairment exists.

Biomarker access is a growing access issue. In the Italian survey, specialists perceived patient reluctance and cost as challenges to biomarker use.[1] The authors concluded that improving referral pathways and biomarker access is essential for timely diagnosis.[1] Health systems preparing for amyloid-targeting therapies need to plan imaging, laboratory and infusion capacity together. Eligibility review, safety monitoring and infusion scheduling all draw on the same constrained specialist teams.

Leaders should test their own route with simple questions. How long does a referred patient wait for a first specialist contact? Who decides which patients need imaging or biomarkers? Which team owns scheduling once a treatment decision is made? The answers often reveal that no single leader can see the whole route. Assigning that visibility to one accountable executive is a low-cost first step. It also gives the board a single point of contact for progress reports.

Executive guidance · System route

Build one visible operating route for Alzheimer’s & Brain Awareness Month.

Use this route as a discussion framework. Replace each stage with the organization’s approved process, qualified roles, current service capacity, and applicable requirements. Do not infer a clinical protocol from the observance title.

The route at a glance

  1. Listen
  2. Clarify entry
  3. Support complex navigation
  4. Protect transitions
  5. Verify and learn

Reliability rule: Every stage needs a named owner, an observable status, an approved escalation path, and a defined signal that shows whether responsibility moved or remained unresolved.

  1. Listen

    Gather questions and friction points from people using the route, frontline teams, and community-facing staff. Separate observed barriers from assumptions.

  2. Clarify entry

    Publish a plain-language first step and identify who receives requests through each approved channel.

  3. Support complex navigation

    Make contact options, receiving services, communication support, transition status, and follow-through visible without assuming one experience or route.

  4. Protect transitions

    Use acknowledgment and status visibility when responsibility moves between services, locations, or organizations.

  5. Verify and learn

    Review unresolved work, repeat contacts, and avoidable handoffs. Use the findings to improve the route rather than blame individuals.

Figure 2

The system route as one flow

The system route as one flowThe five stages of the system route described in this brief, drawn as one flow with a learning loop back to the start. The stages are the page’s original executive guidance, not a clinical protocol.ListenClarify entrySupport complexnavigationProtecttransitionsVerify and learnLearning returns to the start of the route

The five stages of the system route described in this brief, drawn as one flow with a learning loop back to the start. The stages are the page’s original executive guidance, not a clinical protocol.

Data note. Shows sequence and handoffs only; it carries no counts or rates.

Limitation. Local processes may add, merge or reorder stages under organizational policy.

Figure data (5 rows)
Figure 2 data: The system route as one flow
StageWhat the stage requires
ListenGather questions and friction points from people using the route, frontline teams, and community-facing staff. Separate observed barriers from assumptions.
Clarify entryPublish a plain-language first step and identify who receives requests through each approved channel.
Support complex navigationMake contact options, receiving services, communication support, transition status, and follow-through visible without assuming one experience or route.
Protect transitionsUse acknowledgment and status visibility when responsibility moves between services, locations, or organizations.
Verify and learnReview unresolved work, repeat contacts, and avoidable handoffs. Use the findings to improve the route rather than blame individuals.

Equity and trust

Equity gaps in dementia care appear at every step

Disparities begin before treatment. The Carolinas Medicare analysis found that Black beneficiaries were 8% less likely than White beneficiaries to receive dementia medications after adjustment.[14] They also spent 8% more days in skilled nursing facilities.[14] The study noted a shortage of neurologists in counties with high dementia incidence.[14] The authors called for effective system-level approaches to promote equity in diagnosis, treatment and outcomes.[14]

Adherence also differs. In the U.S. medication study, initiation of dementia medications did not vary by ethnoracial group.[15] However, non-Hispanic Black patients were more likely than White patients to be non-adherent (odds ratio 1.50).[15] The authors found that racial disparities diminished when disease severity and socioeconomic factors were controlled.[15] That points leaders toward cost, access and support rather than toward individual blame. It also suggests that equity reviews should include payer, neighborhood and functional status alongside race.

The last year of life shows the sharpest differences. Among 70,650 Medicare decedents with dementia or Parkinson disease in the Carolinas, Black decedents were more likely to receive feeding tube placement (adjusted hazard ratio 2.96).[10] They were more likely to be hospitalized (adjusted hazard ratio 1.28) and less likely to be admitted to hospice (adjusted hazard ratio 0.82).[10] These differences persisted after adjusting for health status and socioeconomic factors.[10] For leaders, they suggest that goals-of-care conversations and hospice referral routes may not be reaching all families equally. Each of those routes has an owner who can review it.

Hospice quality does not fully explain the gap. The national hospice study found that minoritized people with dementia were more likely to be disenrolled even within high-quality hospices.[13] The authors recommended work on both equitable access to high-quality hospices and better care for minoritized patients in all hospices.[13]

Trusted community channels can help close gaps. A faith-integrated Florida program for Black caregivers delivered 28 online workshops from May 2020 to December 2024.[8] The series reached 1,427 preregistered individuals and 1,124 workshop attendees.[8] Findings suggested that the workshops engaged Black communities and supported participant communication.[8] Health systems can partner with programs like this rather than building parallel outreach. Partnership works best when the health system offers a clear clinical route for the questions such programs surface.

A neurologist, a social worker and a nurse navigator review a care plan together on a laptop.
Illustrative image. A faith-integrated workshop series reached Black caregivers through trusted community channels.[8]

Human infrastructure

The human infrastructure behind dementia care

Dementia care relies heavily on primary care, yet many clinicians lack geriatric training. A scoping review of nine U.S. studies examined a telementoring model that links primary care providers with specialist teams.[5] Participation was consistently associated with self-reported gains in knowledge, confidence and communication skills.[5] Sustained practice change and patient-level outcomes were infrequently documented.[5] Leaders should fund such programs and also measure what changes in practice. Referral volume, diagnosis rates and care plan completion are reasonable local signals to track.

Task sharing can extend scarce clinician time. In the digital assessment study, medical assistants administered the test and primary care providers reported increased confidence and reduced stress in diagnosing dementia.[7] Providers preferred the digital assessment over traditional tests.[7] In the memory clinic triage model, a clinical psychologist handled the first structured contact.[11] Both designs place a defined role at a defined step. Clear roles reduce the chance that a referral sits in a shared queue with no owner.

Caregivers are the largest part of the dementia workforce. A real-world texting program supported 147 informal caregivers over six months.[4] Of those caregivers, 12.9% unsubscribed and 68.8% read most texts thoroughly.[4] Preparedness for caregiving and unmet needs improved from pre- to post-program testing.[4] The authors noted that changes were smaller than those seen in efficacy trials, consistent with other implemented programs.[4]

Program fidelity depends on staff. An evaluation of a caregiver support program in 16 adult day service sites found that most caregivers received it with moderate to high fidelity.[9] Higher-fidelity sites delivered more sessions to more caregivers with substantially stronger caregiver benefits.[9] The authors concluded that staff training and program adaptations appear needed for low-fidelity sites.[9]

For executives, the lesson is that caregiver support, navigation and triage are staffed services. They need protected time, training and supervision. They also need measures that show whether families actually received the support. When these roles depend on grant funding, they can disappear just as demand grows. Building them into operating budgets protects the route. Workforce plans should also anticipate added demand from eligibility review and monitoring for new therapies. Those tasks fall on the same neurology, imaging and nursing teams that already carry long waiting lists.

Executive guidance · Operating dashboard

Use a small dashboard to expose friction and ownership.

Do not publish a number until the organization defines its numerator, denominator where relevant, owner, source system, exclusions, review cadence, and limits. The candidates below are management prompts, not benchmarks or reported results.

Four operating signals

Entry-point clarityOwnership reliabilityNavigation and communicationImprovement closure

Each signal pairs an executive question with one candidate local measure, set out below.

Executive guidance · Signal

Entry-point clarity

Can people and staff identify the approved first step without searching across conflicting instructions?

Candidate local measure
Locally defined contact, routing, and repeat-contact signals by channel and service.

Executive guidance · Signal

Ownership reliability

Does a specific team accept each request and make its status visible?

Candidate local measure
Requests without an owner, aged work, transfers, and escalations using locally approved definitions.

Executive guidance · Signal

Navigation and communication

Can people and support networks understand who owns the next step and how to raise an unresolved barrier?

Candidate local measure
Locally defined communication barriers, repeated contacts, transition acceptance, support requests, and route completion.

Executive guidance · Signal

Improvement closure

Does the organization correct recurring friction and report what changed?

Candidate local measure
Selected barriers, assigned actions, completion status, and post-change review.

Figure 4

The operating system behind the dashboard

The operating system behind the dashboardThe four operating signals from this brief’s dashboard, each tied to the candidate owner named in the executive scorecard, around one accountable route. Drawn from the page’s original executive guidance.Accountableoperating route(executive sponsor)Entry-point clarityOwner: Executive sponsor andoperational leadOwnership reliabilityOwner: Operational owner andparticipating teamsNavigation and communicationOwner: Sending and receiving ownersImprovement closureOwner: Improvement owner andexecutive sponsor

The four operating signals from this brief’s dashboard, each tied to the candidate owner named in the executive scorecard, around one accountable route. Drawn from the page’s original executive guidance.

Data note. Structural diagram; no measured values.

Limitation. Owners are candidates to be confirmed locally.

Figure data (4 rows)
Figure 4 data: The operating system behind the dashboard
Operating signalCandidate owner
Entry-point clarityExecutive sponsor and operational lead
Ownership reliabilityOperational owner and participating teams
Navigation and communicationSending and receiving owners
Improvement closureImprovement owner and executive sponsor

Executive guidance · Handoff workflow

Close the loop across teams, settings, and partners.

A handoff is reliable only when the sending party knows who is expected to receive the work, the receiving party acknowledges responsibility, and any unresolved exception remains visible. Local policy and qualified judgment control the actual process.

How responsibility moves

Lane AFrom message to accepted ownership4 steps
Lane BFrom accepted ownership to verified follow-through4 steps

Lane A

From message to accepted ownership

  1. Confirm the approved message and intended audience.
  2. Publish the actual entry point and receiving role.
  3. Acknowledge receipt using the locally approved method.
  4. Escalate when ownership or response remains unclear.

Lane B

From accepted ownership to verified follow-through

  1. Record the next accountable owner and visible status.
  2. State the next owner, approved communication channel, and unresolved status in a form the receiving team can use.
  3. Keep unresolved work visible across boundaries.
  4. Confirm closure or document the continuing exception.

Executive guidance · Executive scorecard

Give leaders one view of route reliability and improvement.

The scorecard keeps review focused on decisions. Leaders should set definitions locally, examine variation without overclaiming cause, and pair quantitative signals with the experience of people who use and operate the route.

Who reviews what

  • Executive sponsor and operational lead
  • Operational owner and participating teams
  • Sending and receiving owners
  • Improvement owner and executive sponsor

Candidate owners named in the scorecard, confirmed locally.

Candidate questions and ownership assignments. These are not external benchmarks.
Operating signalExecutive questionCandidate ownerSuggested review point
Entry-point clarityCan people and staff identify the approved first step without searching across conflicting instructions?Executive sponsor and operational leadAt campaign launch and close
Ownership reliabilityDoes a specific team accept each request and make its status visible?Operational owner and participating teamsAt a locally defined cadence
Navigation and communicationCan people and support networks understand who owns the next step and how to raise an unresolved barrier?Sending and receiving ownersAt a locally defined cadence
Improvement closureDoes the organization correct recurring friction and report what changed?Improvement owner and executive sponsorUntil action is verified

Figure 5

Control points for a reliable dementia care route

Figure 5: Control points for a reliable dementia care route
Control pointRisk if missingOwnerEvidence of control
Workflow-integrated cognitive assessment in primary careImpairment goes unrecognized and diagnosis is delayedPrimary care medical directorPractice-level diagnosis rate and share of eligible patients assessed
Triage of memory clinic referrals by needUrgent cases wait behind routine requestsMemory clinic directorWaiting time by triage level and share redirected to counseling
Linked detection-to-diagnosis handoffCommunity or digital screening produces results without a next stepPopulation health lead with primary careShare of positive screens with a completed clinical follow-up
Medication and therapy follow-through ownerPatients never fill, stop early or miss safety monitoringPharmacy and neurology service line leadersFill, adherence and monitoring completion within locally defined windows
Caregiver support offered and confirmedFamilies carry care without preparation or resourcesSocial work or care navigation managerShare of families offered and receiving support
Equity review of end-of-life and transition measuresReadmissions, hospice gaps and low-value care stay hiddenChief quality officer with health equity leadStratified report on readmission, hospice use and low-value care reviewed by a committee

Control points derived from the cited evidence [4], [7], [10], [11], [12], [13], [15] and this brief’s executive guidance.

Data note. Each row is a control to verify, not a measured result.

Limitation. Owners and evidence of control must follow local policy and applicable requirements.

Public communication

Communicating about brain health in ways that build trust and timely action

Public communication about dementia should lead people to a real next step. The community detection trial found that participants described assessments as personally relevant, clearly communicated and medically meaningful.[3] It also found that a brief self-report questionnaire may serve as a pragmatic first step.[3] Awareness campaigns can borrow that clarity by naming where a concern should go and what will happen next.

Messages must reach caregivers as well as patients. In the texting program, most caregivers rated acceptability at the two highest levels, ranging from 64.3% to 75.9% across four items.[4] The program combined dementia education, skill-building and community resources.[4] Low-cost, remote formats can carry practical information between clinic visits. They also reach caregivers who cannot leave home or take time off work for a class. Health systems can use these channels to explain who to call when needs change. Messages should be written for people under stress, with plain language and a single number or contact point.

Trust depends on who delivers the message. In the Florida workshop series, attendee engagement included information requests, shared personal experiences and gratitude for presenters.[8] Only 106 participants (7.4%) completed post-workshop surveys, so the program planned to improve evaluation.[8] That gap is a reminder that reach and measured impact are different things. Campaigns should plan their evaluation at the start, not after the event.

Measurement and governance close the loop. The primary care assessment study showed that diagnosis rates can be tracked at the practice level and sustained over time.[7] The end-of-life study used recognized low-value and high-value care measures that boards can monitor.[10] Readmission, hospice disenrollment and medication follow-through can all be stratified by race and geography.[12][13][15] Reviewing these measures together keeps attention on the whole route rather than one department.

Leaders should report results honestly, including what did not change. A board that sees diagnosis rates, time to specialist contact, caregiver support uptake and end-of-life measures together will understand the whole route. That view helps the organization connect awareness to a lasting improvement. It also tells families and staff that their concerns are being heard and acted on. Public updates should describe what changed in plain terms and avoid claims the data cannot support.

An older man walks arm in arm with his daughter down a tree-lined sidewalk as a small dog trots ahead.
Illustrative image. Adult day sites that delivered caregiver support with higher fidelity saw stronger caregiver benefits.[9]

Executive guidance · 90-day plan

Turn the observance into one sustained operating change.

The time boxes below are a management framework, not a clinical timeline. Adjust them to risk, scope, governance, resources, stakeholder participation, and applicable review requirements.

Ninety days, three moves

  1. Days 1–30See the current route
  2. Days 31–60Build the reliable path
  3. Days 61–90Make the change visible

Days 1–30 · Listen and map

See the current route

  • Name an executive sponsor and an operational owner.
  • Listen to people using the route and representative frontline teams.
  • Map how Alzheimer’s & Brain Awareness Month communications connect to real entry points, owners, transitions, and escalation.
  • Select one recurring barrier that the organization can responsibly address.

Days 31–60 · Design and test

Build the reliable path

  • Define the trigger, receiving owner, required information, acknowledgment, escalation, and closure signal.
  • Validate the design with every sending and receiving team involved.
  • Validate one complex navigation handoff with people using and operating the route, then correct a barrier.
  • Test the route in more than one representative setting or operating period where practical.

Days 61–90 · Implement and verify

Make the change visible

  • Launch the redesigned route with a small set of locally defined measures.
  • Review unresolved work and recurring friction using a learning approach.
  • Correct implementation barriers and record who owns each remaining dependency.
  • Report what changed, what evidence was reviewed, and what still requires live oversight.

Figure 6

The 90-day plan on one timeline

The 90-day plan on one timelineThe 90-day plan from this brief drawn as a timeline: each action sits in the 30-day window the plan assigns it. The full wording of each action is in the figure data and in the plan above.Day 0Day 30Day 60Day 90Name an executive sponsor and an operational owner.Days 1–30: Name an executive sponsor and an operational owner.Listen to people using the route and representative frontlineteams.Days 1–30: Listen to people using the route and representative frontline teams.Map how Alzheimer’s & Brain Awareness Month communicationsconnect to real entry points, owners, transitions, andescalation.Days 1–30: Map how Alzheimer’s & Brain Awareness Month communications connect to real entry points, owners, transitions, and escalation.Select one recurring barrier that the organization canresponsibly address.Days 1–30: Select one recurring barrier that the organization can responsibly address.Define the trigger, receiving owner, required information,acknowledgment, escalation, and closure signal.Days 31–60: Define the trigger, receiving owner, required information, acknowledgment, escalation, and closure signal.Validate the design with every sending and receiving teaminvolved.Days 31–60: Validate the design with every sending and receiving team involved.Validate one complex navigation handoff with people using andoperating the route, then correct a barrier.Days 31–60: Validate one complex navigation handoff with people using and operating the route, then correct a barrier.Test the route in more than one representative setting oroperating period where practical.Days 31–60: Test the route in more than one representative setting or operating period where practical.Launch the redesigned route with a small set of locallydefined measures.Days 61–90: Launch the redesigned route with a small set of locally defined measures.Review unresolved work and recurring friction using a learningapproach.Days 61–90: Review unresolved work and recurring friction using a learning approach.Correct implementation barriers and record who owns eachremaining dependency.Days 61–90: Correct implementation barriers and record who owns each remaining dependency.Report what changed, what evidence was reviewed, and whatstill requires live oversight.Days 61–90: Report what changed, what evidence was reviewed, and what still requires live oversight.Listen and mapDesign and testImplement and verify

The 90-day plan from this brief drawn as a timeline: each action sits in the 30-day window the plan assigns it. The full wording of each action is in the figure data and in the plan above.

Data note. Time boxes are a management framework, not a clinical timeline.

Limitation. Durations are uniform 30-day windows; real tasks may span windows.

Figure data (12 rows)
Figure 6 data: The 90-day plan on one timeline
WindowAction
Days 1–30 · Listen and mapName an executive sponsor and an operational owner.
Days 1–30 · Listen and mapListen to people using the route and representative frontline teams.
Days 1–30 · Listen and mapMap how Alzheimer’s & Brain Awareness Month communications connect to real entry points, owners, transitions, and escalation.
Days 1–30 · Listen and mapSelect one recurring barrier that the organization can responsibly address.
Days 31–60 · Design and testDefine the trigger, receiving owner, required information, acknowledgment, escalation, and closure signal.
Days 31–60 · Design and testValidate the design with every sending and receiving team involved.
Days 31–60 · Design and testValidate one complex navigation handoff with people using and operating the route, then correct a barrier.
Days 31–60 · Design and testTest the route in more than one representative setting or operating period where practical.
Days 61–90 · Implement and verifyLaunch the redesigned route with a small set of locally defined measures.
Days 61–90 · Implement and verifyReview unresolved work and recurring friction using a learning approach.
Days 61–90 · Implement and verifyCorrect implementation barriers and record who owns each remaining dependency.
Days 61–90 · Implement and verifyReport what changed, what evidence was reviewed, and what still requires live oversight.

Executive guidance · Leadership close

Make Alzheimer’s & Brain Awareness Month a starting point, not an endpoint.

Recognition matters. It becomes durable when leaders also listen, clarify the route, support the people operating it, close an identified gap, and report the result without claiming more than the evidence supports.

Leadership commitment

Make ownership visible, test the route, and report what improved.

Executive action kit · Month observance

Turn Alzheimer’s & Brain Awareness Month into accountable action.

A practical executive framework for access, ownership, handoffs, measurement, and improvement.

Take it with you

Filed under

Chronic Disease and Specialty CarePublic Health and PreventionMonth

Leadership focus

Use this observance to examine navigation, longitudinal ownership, and specialty-care coordination. Select one verified barrier, assign an accountable owner, and carry the improvement beyond the campaign window.

Workforce lens

Ask whether staffing, role clarity, training, tools, workload, and escalation support the people operating the information, assessment navigation, support, and longitudinal follow-through pathway.

Patient and community lens

Make the approved first step clear. Test whether a person can move from information to an acknowledged next action without navigating conflicting instructions.

Equity and access lens

Review communication access, cognitive accessibility, caregiver burden, transportation, digital access, and geographic availability.

Five-minute briefing

Inspect the operating sequence

Listen with people using the pathway, caregivers, clinical teams, rehabilitation, and community supports. Find one fragmented information, a failed transition, or an unresolved support need, then test the locally approved route from entry through acknowledged follow-through.

  1. Listen
  2. Clarify entry
  3. Support complex navigation
  4. Protect transitions
  5. Verify and learn
Leadership actions for this week
  • Name an executive sponsor and frontline operating owner.
  • Ask people using and operating the pathway where ownership becomes unclear.
  • Test one representative route from first question to acknowledged next step.
  • Select one barrier that can be corrected without overstating the evidence.
  • Set a review date and define how completion will be verified.
Candidate measures

Define every numerator, denominator where relevant, owner, data source, exclusions, cadence, and limitation locally. These are management prompts, not external benchmarks.

  • Locally defined contact, routing, and repeat-contact signals by channel and service.
  • Requests without an owner, aged work, transfers, and escalations using locally approved definitions.
  • Locally defined communication barriers, repeated contacts, transition acceptance, support requests, and route completion.
Department readiness checklist
  • The public and staff entry points match the actual approved process.
  • A specific role accepts each request, referral, or escalation.
  • Handoffs include acknowledgment and a visible unresolved state.
  • Language, disability, digital, transportation, and trust barriers receive explicit review.
  • Communications do not introduce unsupported themes, statistics, or clinical advice.
  • A named leader will review what changed after the observance.
Intended audiences
  • Executive and Operational Leaders
  • Patient Experience and Access Leaders
Staff communication template

During Alzheimer’s & Brain Awareness Month, our organization will connect awareness with a practical review of the information, assessment navigation, support, and longitudinal follow-through pathway. Use approved information, identify the correct entry point, confirm ownership when work moves, protect privacy, and escalate unresolved barriers through local channels.

Community communication template

Alzheimer’s & Brain Awareness Month is an opportunity to share trustworthy information and make the next step easier to find. Use our approved channels for information and support. If a request changes hands, our goal is to keep ownership and follow-through visible.

Measurement worksheet
Signal
What observable condition will show whether the route works?
Definition
What is included, excluded, and counted?
Owner
Who reviews the signal and acts on exceptions?
Cadence
When will leaders review it?
Equity check
Which differences require protected, locally appropriate review?
Closure
What evidence will confirm the improvement was completed?
Editorial review
Completed
Source records
2 listed under Authoritative resources
Review standard
Sourced facts remain separated from original executive guidance
Clinical boundary
No new statistical or clinical claim was added by this action kit

Sources and content boundary

Authoritative resources

Use note: All operating models, measures, scorecard questions, and action steps are original executive guidance. This article supports leadership planning and education. It does not replace clinical judgment, emergency procedures, legal advice, professional standards, organizational policy, or applicable federal, state, and local requirements.

Peer-reviewed references

References

Fifteen peer-reviewed sources, newest first. Each was individually verified through authenticated academic research databases. Bracketed numbers in the text link here; the original executive guidance on this page carries no citations because it is guidance, not a sourced claim. Sources last checked in those databases on .

  1. 1. Diagnosis and management of mild cognitive impairment and mild Alzheimer’s disease dementia: Findings from an Italian real-world survey. Journal of Alzheimer’s Disease. 2026:13872877261490595. https://doi.org/10.1177/13872877261490595
  2. 2. Optimizing scalable approaches for early detection of cognitive impairment in primary care. Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring. 2026;18(2):e70393. https://doi.org/10.1002/dad2.70393
  3. 3. Adaptive pathways for multimodal community-based detection of cognitive impairment: the CogScreen I study. Scientific Reports. 2026;16(1):23072. https://doi.org/10.1038/s41598-026-61868-x
  4. 4. Feasibility, acceptability, and pre- post-program outcome changes of the real-world implementation of an informal caregiver support program via text message. Journal of Alzheimer’s Disease. 2026;112(1):405-415. https://doi.org/10.1177/13872877261450936
  5. 5. Impact of Project ECHO on Primary Care Providers’ Knowledge, Confidence, and Skills in Geriatric and Dementia Care: A Scoping Review. Journal of Applied Gerontology. 2026:07334648261478673. https://doi.org/10.1177/07334648261478673
  6. 6. Primary care detection of Alzheimer’s disease using a self-administered digital cognitive test and blood biomarkers. Nature Medicine. 2025;31(12):4131-4139. https://doi.org/10.1038/s41591-025-03965-4
  7. 7. Enhancing early detection of cognitive impairment in primary care with the TabCAT‐BHA. Alzheimer’s & Dementia. 2025;21(7):e70437. https://doi.org/10.1002/alz.70437
  8. 8. Evaluation of the African American Alzheimer’s Caregiver Training and Support Project 2 (ACTS2) Facebook Live Workshop Series: A Mixed Methods Analysis. Journal of Applied Gerontology. 2025;45(8):1485-1497. https://doi.org/10.1177/07334648251378273
  9. 9. Fidelity matters: implementing ADS Plus, an evidence-based program, in multiple adult day service sites. Innovation in Aging. 2025;9(8):igaf074. https://doi.org/10.1093/geroni/igaf074
  10. 10. Racial Disparities in Low-Value Care in the Last Year of Life for Medicare Beneficiaries With Neurodegenerative Disease. Neurology Clinical Practice. 2024;14(2):e200273. https://doi.org/10.1212/cpj.0000000000200273
  11. 11. Psychological telephone triage system for outpatient memory clinics – a way for adaptation to new challenges of increasing dementia prevalence and new treatment options?. International Journal of Clinical and Health Psychology. 2024;24(4):100530. https://doi.org/10.1016/j.ijchp.2024.100530
  12. 12. Disparities in 30‐day readmission rates among Medicare enrollees with dementia. Journal of the American Geriatrics Society. 2023;71(7):2194-2207. https://doi.org/10.1111/jgs.18311
  13. 13. Hospice Quality, Race, and Disenrollment in Hospice Enrollees With Dementia. Journal of Palliative Medicine. 2023;26(8):1100-1108. https://doi.org/10.1089/jpm.2023.0011
  14. 14. Racial/ethnic disparities in dementia incidence, outcomes, and health‐care utilization. Alzheimer’s & Dementia. 2022;19(6):2376-2388. https://doi.org/10.1002/alz.12891
  15. 15. Alzheimer’s disease medication use and adherence patterns by race and ethnicity. Alzheimer’s & Dementia. 2022;19(4):1184-1193. https://doi.org/10.1002/alz.12753

Claim-to-source matrix

What each source supports

Every sourced claim in the new sections maps to the references that support it, the section where it is used, and the limitation a reader should keep in mind. Original executive guidance carries no sources because it is guidance, not a finding.

Claim-to-source matrix
Claim groupSourcesYearsUsed inLimitation
Diagnostic delays and biomarker use[1]2026Executive openingPhysician-reported Italian survey; biomarker access and health system differ from the U.S.
Accuracy of digital and blood-based detection in primary care[6] [2]2026, 2025Current evidenceProof-of-concept and cross-sectional studies; performance may differ in other populations and workflows.
Implementation of workflow-integrated cognitive assessment[7]2025Current evidenceOne family medicine clinic; adoption and diagnosis rates, not patient outcomes.
Community-based tiered detection and primary care linkage[3]2026Continuum of careMunich senior centers; highly educated sample; framework is hypothesis-generating.
Medication initiation, adherence and discontinuation[15]2022Continuum of careSurvey-linked claims from 2000 to 2016; predates new therapies.
Racial disparities in readmission[12]2023Continuum of care2014 fee-for-service Medicare claims; Black and White beneficiaries only.
Hospice quality and disenrollment by race and ethnicity[13]2023Continuum of careMedicare hospice enrollees 2012 to 2017; quality measured by one survey rating.
Memory clinic telephone triage and waiting times[11]2024AccessSingle specialized memory clinic; retrospective before-and-after comparison.
Disparities in utilization, medications and end-of-life care[14] [10]2024, 2022Equity and trustNorth and South Carolina Medicare claims 2013 to 2017; fee-for-service only.
Faith-integrated community workshops for Black caregivers[8]2025Equity and trustReach and engagement data; 7.4% survey completion limits outcome conclusions.
Telementoring for primary care dementia skills[5]2026Human infrastructureScoping review of nine studies; mostly self-reported provider outcomes.
Caregiver support by text message and in adult day services[4] [9]2026, 2025Human infrastructureObservational pre-post data and fidelity analysis; effects smaller than in efficacy trials.
Greg Wahlstrom in his office at The Healthcare Executive

About the author

Greg Wahlstrom

MBAHCM

President and Chief Executive Officer, The Healthcare Executive

©2014 – 2026 The Healthcare Executive. All rights reserved.

Back to the contents

Health Observance Calendar

See next month’s observances before it starts.

One email ahead of each month with the health observances coming up and the executive briefs that go with them.

Sent by The Healthcare Executive. Unsubscribe at any time. See our Privacy Policy.